Literature DB >> 21119614

Portal hypertension: Nonselective β-blockers in patients with refractory ascites.

Juan Carlos Garcia-Pagán.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21119614     DOI: 10.1038/nrgastro.2010.185

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  7 in total

1.  Beta-blockers in cirrhosis: friend and foe?

Authors:  Florence Wong; Francesco Salerno
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

2.  The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients.

Authors:  P Sharma; A Kumar; S Jha; S R Mishra; B C Sharma; S K Sarin
Journal:  Aliment Pharmacol Ther       Date:  2010-03-23       Impact factor: 8.171

3.  Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.

Authors:  J Llach; P Ginès; V Arroyo; A Rimola; L Titó; S Badalamenti; W Jiménez; J Gaya; F Rivera; J Rodés
Journal:  Gastroenterology       Date:  1988-02       Impact factor: 22.682

4.  Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.

Authors:  T Poynard; P Calès; L Pasta; G Ideo; J P Pascal; L Pagliaro; D Lebrec
Journal:  N Engl J Med       Date:  1991-05-30       Impact factor: 91.245

5.  Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.

Authors:  Thomas Sersté; Christian Melot; Claire Francoz; François Durand; Pierre-Emmanuel Rautou; Dominique Valla; Richard Moreau; Didier Lebrec
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

6.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study.

Authors: 
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

7.  Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.

Authors:  D Lebrec; T Poynard; P Hillon; J P Benhamou
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

  7 in total
  2 in total

Review 1.  Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.

Authors:  Antonio Facciorusso; Sunil Roy; Sarantis Livadas; Adwalia Fevrier-Paul; Clara Wekesa; Ismail Dogu Kilic; Amit Kumar Chaurasia; Mina Sadeq; Nicola Muscatiello
Journal:  Dig Dis Sci       Date:  2018-05-03       Impact factor: 3.199

2.  Improving survival in decompensated cirrhosis.

Authors:  Amar Nath Mukerji; Vishal Patel; Ashokkumar Jain
Journal:  Int J Hepatol       Date:  2012-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.